Basics Cel-Sci Corporation CEL-SCI Corp is a biotechnology company. It is engaged in the research and development directed at improving the treatment of cancer and other diseases by utilizing the immune system, the body's natural defense system. IPO Date: December 1, 1984 Sector: Healthcare Industry: Biotech Market Cap: $51.56M Activated in VL: True Average Daily Range Avg Daily Range: $0.20 | 4.96% Avg Daily Range (30 D): $0.31 | 4.30% Avg Daily Range (90 D): $0.42 | 4.81% Institutional Daily Volume Avg Daily Volume: .81M Avg Daily Volume (30 D): .07M Avg Daily Volume (90 D): .16M Trade Size Avg Trade Size (Sh.): 435 Avg Trade Size (Sh.) (30 D): 137 Avg Trade Size (Sh.) (90 D): 117 Institutional Trades Total Inst.Trades: 351 Avg Inst. Trade: $1.44M Avg Inst. Trade (30 D): $1.32M Avg Inst. Trade (90 D): $1.32M Avg Inst. Trade Volume: M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.59M Avg Closing Trade (30 D): $1.32M Avg Closing Trade (90 D): $1.32M Avg Closing Volume: 5.66K     News Nov 4, 2024 @ 8:52 PM 3 Interesting Emerging Growth Stock Ideas From the... Source: Professor Ari Zoldan Dec 4, 2023 @ 6:10 PM Why U Power Shares Are Trading Lower By Around 54%... Source: Lisa Levin Jul 18, 2023 @ 5:00 PM Why Lixte Biotechnology Shares Are Trading Lower B... Source: Lisa Levin Jul 18, 2023 @ 1:51 PM US Stocks Mixed; Bank of America Tops Q2 Views Source: Lisa Levin Jul 18, 2023 @ 12:12 PM Why Biophytis Shares Are Trading Higher By 54%; He... Source: Lisa Levin Financials   TTM Q3 2025 Q2 2025 Basic EPS Diluted EPS $5.66 $-1.36 $-.08 Revenue $ .05M $ -.17M $ -.18M Gross Profit $ $ $ Net Income / Loss $ -25.42M $ -5.66M $ -6.57M Operating Income / Loss $ -24.9M $ -5.49M $ -6.39M Cost of Revenue $ $ $ Net Cash Flow $ 1.41M $ -.13M $ PE Ratio 1.14     Splits May 20, 2025:   1:30 Jun 15, 2017:   1:25 Sep 25, 2013:   1:10